Newspaper advertisement pertaining to financial results for quarter and year ended on March 31, 2025
Awaiting price reaction for this filing.
J.B. Chemicals & Pharmaceuticals Ltd. (BSE: 506943) has published its audited financial results for the quarter and full year ended March 31, 2025 in Business Standard and Sakal newspapers on May 15, 2025. This newspaper advertisement is a mandatory disclosure under Regulation 47(1) of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The results were approved at the Board of Directors meeting held on May 14, 2025. The detailed financial results along with the Auditors' Report have been made available on the BSE website (www.bseindia.com) and can also be accessed via a QR code provided in the newspaper advertisement. The filing was signed by Sandeep Phadnis, Vice President - Secretarial & Company Secretary, and references CEO & Whole-Time Director Nikhil Chopra.
This is a routine regulatory compliance filing with no direct material impact on shareholders or the stock price. It simply fulfils SEBI's public disclosure requirement to ensure financial results reach a wider audience beyond digital channels.